COMPARISON OF ROPIVACAINE (0.5%) AND LEVOBUPIVACAINE (0.5%) IN SUPRACLAVICULAR BRACHIAL PLEXUS BLOCK IN UPPER LIMB ORTHOPAEDIC SURGERIES
Phase 3
- Conditions
- Health Condition 1: S42- Fracture of shoulder and upper arm
- Registration Number
- CTRI/2023/06/054260
- Lead Sponsor
- YOGINI KELAWALA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients with ASA Grade I,II and III of either gender.
All patients undergoing elective and emergency upper limb orthopaedic surgeries.
Age group of 18 to 65 years.
Patient with body weight upto 80 kg.
Exclusion Criteria
Patient having hypersensitivity to the study drugs by taking history.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To estimate onset of sensory block in both the groups. <br/ ><br>To estimate duration of sensory block in both the groups. <br/ ><br>To estimate onset of motor block in both the groups. <br/ ><br>To estimate duration of motor block in both the groups. <br/ ><br>To access time of rescue analgesia in both the groups. <br/ ><br>Timepoint: AT THE END OF 15 MONTHS
- Secondary Outcome Measures
Name Time Method To observe changes in HR,MAP, SpO2 in both the groups. <br/ ><br>To compare side effects like hypotension, bradycardia, nausea, vomiting in both the groups. <br/ ><br>Timepoint: AT THE END OF 15 MONTHS